[BMJ] P23 Efficacy of elafibranor in primary biliary cholangitis: results from the variable double-blind period of ELATIVE(R), a randomised, placebo-controlled phase III trial

FlyingPenguin Post time 2 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-11-24 02:51
Reward20points

journalㄩP23 Efficacy of elafibranor in primary biliary cholangitis: results from the variable double-blind period of ELATIVE(R), a randomised, placebo-controlled phase III trial

AuthorsㄩChristopher L Bowlus; Kris V Kowdley; Cynthia Levy; Ulus Akarca; Mario Alvares-Da-Silva; Pietro Andreone; Marco Arrese; Christophe Corpechot; Sven Francque; Michael Heneghan; Pietro Invernizzi; David Jones; Frederik Kruger; Eric Lawitz; Marlyn J Mayo; Mitchell Shiffman; Mark G Swain; Jos谷 Miguel Valera; Victor Vargas Blasco; John M Vierling; Alejandra Villamil; Julie Dietrich; Doctor Jianfen Shu; Nuno Antunes; Marwan Sleiman; Nathan Touati; Jorn M Schattenberg

Published dateㄩ2024-10-

DOIㄩ10.1136/gutjnl-2024-basl.34

PDF linkㄩhttps://syndication.highwire.org ... gutjnl-2024-BASL.34

Article linkㄩhttps://doi.org/10.1136/gutjnl-2024-basl.34

Article SourceㄩBMJ Publishing Group Ltd and British Society of Gastroenterology﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    705


Return to the list